Cleanroom Construction and Installation

Table of Contents Upgrading your containment classification isn’t just a compliance exercise. It’s a strategic decision that affects your facility’s future, your team’s safety, and your organisation’s ability to compete. Why the PC2 to PC3 Transition Deserves More Than a Checklist Many organisations approach a biosafety uplift the same way they’d approach a renovation. They […]

Table of Contents Introduction Cleanroom environments form the backbone of Australia’s pharmaceutical, biotechnology, and medical device manufacturing sectors. These controlled spaces maintain specific environmental conditions that protect sensitive processes from contamination. At the heart of every effective cleanroom lies its HVAC (Heating, Ventilation, and Air Conditioning) system – the unsung hero that maintains air quality,

Table of Contents Integrating cleanrooms into existing facilities presents unique challenges for Australian pharmaceutical, biotechnology, and medical device manufacturers. The pressure to maintain production while upgrading infrastructure requires strategic planning and expert execution. With strict Therapeutic Goods Administration (TGA) requirements governing these controlled environments, organisations must balance compliance, operational efficiency, and cost considerations. This article

Table of Contents Operational downtime during cleanroom construction represents a significant challenge for Australian pharmaceutical, biotechnology, and medical device manufacturers. With downtime costs averaging $23,000 per hour in pharmaceutical manufacturing and potentially reaching millions for biologics production, minimising disruption is critical for maintaining business continuity. Australian companies face unique pressures with TGA regulations requiring continuous